{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:42:50Z","timestamp":1790764970256,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer New York","isbn-type":[{"value":"9781493989485","type":"print"},{"value":"9781493989492","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8949-2_13","type":"book-chapter","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T23:14:30Z","timestamp":1544570070000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of C3 Nephritic Factors by ELISA"],"prefix":"10.1007","author":[{"given":"Lillemor","family":"Skattum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"1","key":"13_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00467-015-3310-4","volume":"32","author":"M Riedl","year":"2017","unstructured":"Riedl M, Thorner P, Licht C (2017) C3 Glomerulopathy. Pediatr Nephrol 32(1):43\u201357","journal-title":"Pediatr Nephrol"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2016.06.001","volume":"169","author":"M Egan","year":"2016","unstructured":"Egan M, Sullivan K, Frazer-Abel A, Cunningham-Rundles C (2016) A healthy female with C3 hypocomplementemia and C3 nephritic factor. Clin Immunol 169:14\u201315","journal-title":"Clin Immunol"},{"issue":"6008","key":"13_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.1.6008.501-a","volume":"1","author":"A Karstorp","year":"1976","unstructured":"Karstorp A (1976) C3 activator and hypocomplementaemia in a \"healthy\" woman. Br Med J 1(6008):501\u2013502","journal-title":"Br Med J"},{"issue":"1","key":"13_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.116.1.1","volume":"116","author":"MR Daha","year":"1976","unstructured":"Daha MR, Fearon DT, Austen KF (1976) C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol 116(1):1\u20137","journal-title":"J Immunol"},{"issue":"1","key":"13_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","volume":"83","author":"A Misra","year":"2004","unstructured":"Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83(1):18\u201334","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"13_CR6","first-page":"341","volume":"92","author":"B Teisner","year":"1984","unstructured":"Teisner B, Elling P, Svehag SE et al (1984) C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C 92(6):341\u2013349","journal-title":"Acta Pathol Microbiol Immunol Scand C"},{"issue":"1","key":"13_CR7","first-page":"33","volume":"43","author":"MR Daha","year":"1981","unstructured":"Daha MR, Van Es LA (1981) Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. Immunology 43(1):33\u201338","journal-title":"Immunology"},{"issue":"10","key":"13_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.2012.250","volume":"82","author":"D Paix\u00e3o-Cavalcante","year":"2012","unstructured":"Paix\u00e3o-Cavalcante D, L\u00f3pez-Trascasa M, Skattum L et al (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82(10):1084\u20131092","journal-title":"Kidney Int"},{"issue":"1","key":"13_CR9","first-page":"12","volume":"32","author":"DM Scott","year":"1978","unstructured":"Scott DM, Amos N, Sissons JG et al (1978) The immunoglobulin nature of nephritic factor (NeF). Clin Exp Immunol 32(1):12\u201324","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"13_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(82)90386-6","volume":"51","author":"U Rother","year":"1982","unstructured":"Rother U (1982) A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes. J Immunol Methods 51(1):101\u2013107","journal-title":"J Immunol Methods"},{"key":"13_CR11","first-page":"311","volume":"11","author":"DK Peters","year":"1972","unstructured":"Peters DK, Martin A, Weinstein A et al (1972) Complement studies in membranoproliferative glomerulonephritis. Clin Exp Immunol 11:311\u2013320","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"13_CR12","first-page":"391","volume":"18","author":"DG Williams","year":"1974","unstructured":"Williams DG, Peters DK, Fallows J et al (1974) Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol 18(3):391\u2013405","journal-title":"Clin Exp Immunol"},{"issue":"1\u20132","key":"13_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0022-1759(93)90160-9","volume":"159","author":"J Seino","year":"1993","unstructured":"Seino J, vd Wall Bake WL, van Es LA, Daha MR (1993) A novel ELISA assay for the detection of C3 nephritic factor. J Immunol Methods 159(1\u20132):221\u2013227","journal-title":"J Immunol Methods"},{"issue":"2","key":"13_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0090-1229(90)90144-F","volume":"56","author":"Y Tanuma","year":"1990","unstructured":"Tanuma Y, Ohi H, Hatano M (1990) Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF. Clin Immunol Immunopathol 56(2):226\u2013238","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"13_CR15","first-page":"73","volume":"65","author":"TE Mollnes","year":"1986","unstructured":"Mollnes TE, Ng YC, Peters DK, Lea T et al (1986) Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. Clin Exp Immunol 65(1):73\u201379","journal-title":"Clin Exp Immunol"},{"key":"13_CR16","doi-asserted-by":"crossref","unstructured":"Marinozzi MC, Chauvet S, Le Quintrec M et al (2017) C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney Int. pii: S0085-2538(17)30309-5","DOI":"10.1016\/j.kint.2017.04.017"},{"issue":"6","key":"13_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2796.1997.tb00018.x","volume":"242","author":"L Skattum","year":"1997","unstructured":"Skattum L, M\u00e5rtensson U, Sj\u00f6holm AG (1997) Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies. J Intern Med 242(6):455\u2013464","journal-title":"J Intern Med"}],"container-title":["Methods in Molecular Biology","Autoantibodies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8949-2_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T01:31:08Z","timestamp":1694482268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8949-2_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"ISBN":["9781493989485","9781493989492"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8949-2_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]}}}